Close

Merck's (MRK) KEYTRUDA sBLA in NSCLC Accepted for FDA Priority Review

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/19/2024

1. NFLX
2. TSM
3. ISRG
4. INFY
5. SNV
6. SPY
7. PPG
8. JWN
9. BX
10. TSLA


Go back to Merck's (MRK) KEYTRUDA sBLA in NSCLC Accepted for FDA Priority Review
Merck & Co. (NYSE: MRK) Delayed: 125.07 -0.16 (0.13%)
Previous Close $125.23    52 Week High $65.46 
Open $125.65    52 Week Low $47.97 
Day High $126.03    P/E 85.08 
Day Low $124.98    EPS $1.47 
Volume 1,268,320